Conference Programme Updates : ASCAT 2018

2018 Annual Scientific Conference on Sickle Cell and Thalassaemia is one of the must attend events of the year for consultants and specialist psychologists, nurses, scientists and all relevant experts. 

This is the 12th consecutive opportunity to see the latest advances in diagnosis, treatment and emerging fields in haemoglobinopathies. It is an opportunity to interact on the latest advances in clinical care, transition services, and emerging new therapies including updates for curative treatment options. 

Update : Session Reveal

Day Two
14.00 - 15:40  - Parallel Session : Chronic organ damage in Sickle Cell Disease 

Chair – Dr Giovanna Russo

14.00 - 14.25 - Mina Abedina and Hatel Bhatt - Case reviews exploring the social, emotional and cognitive functioning of children and adolescents with Sickle Cell Disease
14.25 - 14.50  - Dr. Kofi Anie, UK - Impact of social stigma on coping with Sickle Cell Disease
16.35 - 17:05 - Dr. Marsha Treadwell, USA - Influence of religiosity and spirituality on coping and research participation in Sickle Cell Disease

14.00 - 14.20 – Dr. Fenella Kirkham, UK – Stroke in Sickle Cell Disease
14.20 - 14.40 - Dr. Raffaela Colombatti, Italy - CNS abnormalities in children with SCD- beyond stroke and silent infarcts
14.40 - 15.00 - Dr. Anne Greenough, UK - Asthma treatment in Sickle Cell Disease                                                                        15.00 - 15.20 - Dr. Josh Wright, UK - Chronic liver disease in adults with Haemoglobinopathy
15.20 - 15.40 - Dr. Claire Sharpe, UK - Renal Disorders in adults with SCD

Update : Session Reveal

Day Two
11.00 - 13:05 - Thalassaemia : New Insights

Chair – Dr Mark Velangi

11.00 - 11.25 - Dr. Paul Telfer, UK - Collaborative research and datasets across Europe
11.25 - 11.50  - Dr. Aurelio Maggio, Italy - New insights into genotype phenotype correlations
11.50 -12.15 - Dr. Antonio Piga, Italy - Targeting ineffective erythropoiesis
12.15 - 12.40  - Dr. Noemi Roy, UK - Building blocks of genome therapies
12.40 -13.05 - Dr. Mohsin Badat, UK - Genome editing to ameliorate thalassaemia major phenotype 

Update : Session Reveal

Day Two
08:40 - 10:40 -Thalassaemia

Chair – Dr. Ali Taher

08.40 - 09.05 - Dr. Vip Vipraksit, Thailand - Update on Haemoglobin H Disease
09.05 - 09.30 - Dr. Ali Taher, Lebanon - Thalassaemia and Cancer
09.30 – 09:55 - Dr. Salwa Hindawi, Saudi Arabia - Update Experience in Transfusion
09.55 – 10.20 - Dr. Antonis Kattamis, Greece - Chelation therapy challenges in Thalassemia
10.20 - 10.40 - Dr. Alessia Pepe, Italy - Cardiac Complication in Thalassaemia

Update : Session Reveal

Day One
15.40-17.30 -  Sickle Cell Disease

Paediatrics : Chair – Dr Corinna MacMahon

15.45 – 16.10 - Dr. Helen New, UK - Automated red cell exchange (elective and 24/7 emergency services) 
16.10 – 16.35  - Dr. Mona El-Ghamrawy, Egypt - Stroke in childhood
16.35 - 17:05 - Dr. Subarna Chakravarthy, UK - Liver problems in SCD

Adult : Chair – Dr Biree Andemariam

15.45 – 16.10 – Dr. Wale Atoyebi, UK – Hydroxyurea in Adults with SCD
16.10 – 16.35 - Dr. Jo Howard, UK - Acute chest syndrome
16:35 - 17.05  - Dr. Caterina Minniti, USA - Pulmonary hypertension
17:05 - 17:30 - Mr Luhanga Musumadi, UK - Engagement with adolescents and young adults

Update : Session Reveal

Day One
13.30-15.20 - Pain Management Syposium

Chair – Dr. Deepika Darbari

13.30 – 13.55 - Dr. Deepika Darbari, US - Pain mechanisms and phenotypes in SCD
13.55 – 14.20 - Dr. Wally Smith, US - Chronic pain in SCD
14.20 – 14.40 - Dr. Antonio Piga, Italy - Pain in Thalassemia: Differential diagnosis
14.40 – 15. 00 - Dr. Andrew Campbell, US - SCD pain around the globe (CASIRE group) 
15. 00 – 15.20 - Dr. Kalpna Gupta, US - Targeting novel mechanisms of pain in sickle cell disease

Update : Session Reveal

Day One
10.55-12.50 - Sickle Cell Cohort Studies and Long-Term Outcomes

Chair – Dr. Winfred Wang

10.55 – 11.20 – Dr. Winfred Wang - US Sickle cell Cohort (USA- CSSCD)
11.20 – 11.40 – Dr. Beatrice Gulbis - Belguim: Neonatal Screening for Sickle Cell Disease Improves Outcome
11.40 – 12.00- Dr. Kwaku Ohene-Frempong - Director emeritus of the Comprehensive Sickle Cell Center, President Sickle Cell Foundation of Ghana (20mins)
12.00 – 12.30 – Dr. Anie Kofi/ Dr Lewis Hsu/ Dr. Andrea Lamont - A sustainable Sickle cell cohort –The role of community workers training implementation in Nigeria
12.30 – 12.50 – Dr. Fred Piel - UK: Epidemiology in Sickle Cell Disease

Update : Abstracts

The abstract submission process is your opportunity to help shape the content, to share your work with your peers and raise your professional profile.

2018 categories include:

Basic sciences-pathology and pathophysiology
Newborn screening; community engagement
Clinical and community implementation research
Public Health and Health Education
Psychology, education and quality of life
Ageing and haemoglobinopathies
Other aspects of haemaoglobinopathies

Entry deadline for abstracts is 18 August 2018 - Deadline has now passed

Selected presenters of abstracts (the designated presenter) will receive free registration courtesy of Pfizer and Global Therapeutics funding.